Notice: The NSCA website is scheduled to undergo system maintenance from 12:00 AM - 2:30 AM EST. During this time, there may be short service interruptions across the site and some parts of the site may not be accessible. We apologize for any inconvenience while we work to improve the website experience and security.

0

Notice: The NSCA website is scheduled to undergo system maintenance from 12:00 AM - 2:30 AM EST. During this time, there may be short service interruptions across the site and some parts of the site may not be accessible. We apologize for any inconvenience while we work to improve the website experience and security.

Melatonin Supplementation in Adults – Is it Safe and Effective?

by Dr Carmine R. Grieco III, CSCS,*D
Personal Training Quarterly June 2021
Vol 8, Issue 1

Share:
Available to:
Members only
Audience:
Personal trainers
Topics:
Nutrition

A client asks you about melatonin, are you prepared to answer? This article explores the efficacy and safety of supplemental melatonin as a sleep aid in adults.

Paywall block issue

This article is not configured properly for members or paid content.
isMemberOnly: {{isMemberOnly}} | isPaidContent: {{isPaidContent}}
spc: One or more parts of the product SPC is missing.

Read the full article

View the video

Login to view more


{{discountDesc}} Valid thru {{discountEnds}}

This {{ogType == 'video.other' ? 'video':'article'}} is available with a NSCA membership

This {{ogType == 'video.other' ? 'video':'article'}} can be purchased for {{prices}}
Price includes membership pricing and promotions

Purchase this {{ogType == 'video.other' ? 'video':'article'}}. Price range: {{prices}}
Price range includes membership pricing and promotions

Become a Member Add to Cart Login

This article originally appeared in Personal Training Quarterly (PTQ)—a quarterly publication for NSCA Members designed specifically for the personal trainer. Discover easy-to-read, research-based articles that take your training knowledge further with Nutrition, Programming, and Personal Business Development columns in each quarterly, electronic issue. Read more articles from PTQ »

Share:

References

1. Andersen, LPH, Gögenur I, Rosenberg, J and Reiter, RJ. The safety of melatonin in humans. Clinical Drug Investigation 36(3): 169-175, 2016.

2. Auld, F, Maschauer, EL, Morrison, I, Skene, DJ and Riha, RL. Evidence for the efficacy of melatonin in the treatment of primary adult sleep disorders. Sleep Medicine Reviews 34: 10-22, 2017.

3. Besag, FMC, Vasey, MJ, Lao, KSJ and Wong, ICK. Adverse events associated with melatonin for the treatment of primary or secondary sleep disorders: A systematic review. CNS Drugs 33(12): 1167-1186, 2019.

4. Brzezinski, A, Vangel, MG, Wurtman, RJ, Norrie, G, Zhdanova, I, Ben-Shushan, A, and Ford, I. Effects of exogenous melatonin on sleep: A meta-analysis. Sleep Medicine Reviews 9(1): 41-50, 2005.

5. Centers for Disease Control and Prevention. Short sleep duration among US adults. Retrieved December 11, 2020 from https://www.cdc.gov/sleep/data_statistics.html.

6. Chong, Y, Fryer, CD, and Gu, Q. Prescription sleep aid use among adults: United States, 2005-2010. NCHS Data Brief 127: 1-8, 2013.

7. Clarke, TC, Black, LI, Stussman, BJ, Barnes, PM, and Nahin, RL. Trends in the use of complementary health approaches among adults: United States, 2002-2012. National Health Statistics Reports 10(79): 1-16, 2015.

8. Claustrat, B, and Leston, J. Melatonin: Physiological effects in humans. Neuro-Chirurgie 61(2-3): 2015.

9. Costello, RB, Lentino, CV, Boyd, CC, O’Connell, ML, Crawford, CC, Sprengel, ML, and Deuster, PA. The effectiveness of melatonin for promoting healthy sleep: A rapid evidence assessment of the literature. Nutrition Journal 13: 2014.

10. Erland, LAE, and Saxena, PK. Melatonin natural health products and supplements: Presence of serotonin and significant variability of melatonin content. Journal of Clinical Sleep Medicine 13(2): 275-281, 2017.

11. Ferracioli-Oda, E, Qawasmi, A, and Bloch, MH. Meta-analysis: Melatonin for the treatment of primary sleep disorders. PLoS One 8(5): 2013.

12. Foley, HM, and Steel, AE. Adverse events associated with oral administration of melatonin: A critical systematic review of clinical evidence. Complementary Therapies in Medicine 42: 65-81, 2019.

13. Gonciarz, M, Mularczyk, A, Szkudłapski, D, Konturek, SJ, and Konturek, PC. A case of melatonin-induced biochemical flare in a patient with primary sclerosing cholangitis with features of autoimmune hepatitis. Przeglad Gastroenterologiczny 14(2): 157-159, 2019.

14. Grigg-Damberger, MM, and Ianakieva, D. Poor quality control of over-the-counter melatonin: What they say is often not what you get. Journal of Clinical Sleep Medicine 13(2): 275-281, 2017.

15. Härtter, S, Nordmark, A, Rose, DM, Bertilsson, L, Tybring, G, and Laine, K. Effects of caffeine intake on the pharmacokinetics of melatonin, a probe drug for CYP1A2 activity. British Journal of Clinical Pharmacology 56(6): 679-682, 2003.

16. Herxheimer, A, and Petrie, KJ. Melatonin for the prevention and treatment of jet lag. The Cochrane Database of Systematic Review 2: 2002.

17. Hilli, J, Korhonen, T, Turpeinen, M, Hokannen, J, Mattila, S, and Laine, K. The effect of oral contraceptives on the pharmacokinetics of melatonin in healthy subjects with CYP1A2g. -163C>A polymorphism. Journal of Clinical Pharmacology 48(8): 986-984, 2008.

18. Hong, YG, and Riegler, JL. Is melatonin associated the development of autoimmune hepatitis? Journal of Clinical Gastroenterology 25(1): 376-378, 1997.

19. Li, T, Jiang, S, Han, M, Yang, Z, Lv, J, Deng, et al. Exogenous melatonin as a treatment for secondary sleep disorders: A systematic review and meta-analysis. Frontiers in Neuroendocrinology 52: 22-28, 2018.

20. Liira, J, Verbeek, JH, Costa, G, Driscoll, TR, Sallinen, M, Isotalo, LK, and Ruotsalainen, JH. Pharmacological interventions for sleepiness and sleep disturbances caused by shift work. The Cochrane Database of Systematic Reviews 8: 2014.

21. Mordor Intelligence. Melatonin market – Growth, trends, and forecast (2020 – 2025). Retrieved December 2, 2020 from https://www.mordorintelligence.com/industry-reports/ melatonin-market.

22. Nawaz, MA, Huang, Y, Bie, Z, Ahmed, W, Reiter, RJ, Niu, M, and Hameed, S. Melatonin: Current status and future perspectives in plant science. Frontiers in Plant Science 11: 2016.

23. Newmaster, SG, Grguric, M, Shanmughanandhan, D, Ramalingam, S, and Ragupathy, S. DNA barcoding detects contamination and substitution in North American herbal products. BMC Medicine 11: 2013.

24. Pierce, M, Linnebur, SA, Pearson, SM, and Fixen, DR. Optimal melatonin dose in older adults: A clinical review of the literature. The Senior Care Pharmacist 34(7): 419-431, 2019.

25. Reiter, RJ. The pineal gland and melatonin in relation to aging: A summary of the theories and of the data. Experimental Gerontology 30(3-4): 1995.

26. Reiter, RJ, Mayo, JC, Tan, DX, Sainz, RM, Alatorre-Jimenez, M, and Qin, L. Melatonin as an antioxidant: Under promises but over delivers. Journal of Pineal Research 61(3): 253-278, 2016.

27. Sateia, MJ, Buysse, DJ, Krystal, AD, Neubauer, DN and Heald, JL. Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: An American Academy of Sleep Medicine clinical practice guideline. Journal of Clinical Sleep Medicine 13(2): 2017.

28. Tournas, VH. Microbial contamination of select dietary supplements. Journal of Food Safety 29: 430-442, 2009.

29. Ursing, C, von Bahr, C, Brismar, K, and Röjdmark, S. Influence of cigarette smoking on melatonin levels in man. European Journal of Clinical Pharmacology 61(3): 197-201, 2005.

30. Vural, EMS, van Munster, BC, and de Rooij, SE. Optimal dosages for melatonin supplementation therapy in older adults: A systematic review of current literature. Drugs and Aging 31(6): 441-451, 2014.

31. Xie, Z, Chen, F, Li, WA, Geng, X, Li, C, Meng, X, et al. A review of sleep disorders and melatonin. Neurological Research 39(6): 559-565, 2017.

32. Zhang, Q, Gao, F, Zhang, S, Sun, W, and Li, Z. Prophylactic use of exogenous melatonin and melatonin receptor agonists to improve sleep and delirium in intensive care units: A systematic review and meta-analysis of randomized controlled trials. Sleep and Breathing 23(4): 1059-1070, 2019.

33. Zhang, R, Wang, X, Ni, L, Di, X, Ma, B, Niu, S, et al. COVID-19: Melatonin as a potential adjuvant treatment. Life Sciences 250, 2020.

Photo of Dr Carmine R. Grieco III, PhD, CSCS,*D
About the author

Dr Carmine R. Grieco III, PhD, CSCS,*D

Contact Carmine Grieco

Contact Carmine Grieco

Your first name is required.
Your last name is required.
Your email is required.
Your message is required.
Your reCaptcha is required.

Your email was successfully sent to Carmine Grieco

Carmine Grieco received his Doctoral degree from Old Dominion University at the age of 43 and is now an Assistant Professor of Kinesiology at Colorado ...

View full biography
Available to:
Members only
Audience:
Personal trainers
Topics:
Nutrition
#everyonestronger #everyonestronger

has been added to your shopping cart!

Continue Shopping Checkout Now